The policy brief in context
On July 22, 2026, The New York Times published Trump Administration Says Surprise Billing Law Is Being ‘Gamed’ by Doctors by Sarah Kliff, Margot Sanger-Katz, and Alicia Parlapiano. The report examined the federal IDR system, large payment determinations, and concerns raised by the administration.
RevGuard's July 2026 policy brief responds to that coverage and challenges aspects of its framing. The brief compares the reporting with information attributed to the Congressional Budget Office, Centers for Medicare & Medicaid Services, Congressional Research Service, Government Accountability Office, insurance-industry reporting, and peer-reviewed research.
The result is a useful policy argument, but providers still need to separate system-wide statistics from claim-level legal analysis. National figures can explain the environment. They do not establish whether a particular service is eligible, whether a deadline was preserved, or which recovery path applies.
IDR volume needs a denominator
RevGuard reports that fewer than 0.05% of commercial claims reach IDR arbitration, citing the CBO's discussion of insurer survey data. The brief also reports that approximately 79% of No Surprises Act-eligible claims resolve when the provider accepts the insurer's initial payment. This effectively means that 79% of No Surprises Act-eligible claims go unarbitrated.
Those figures matter because IDR filings represent the disputed residue of a much larger claims system. They do not show that every disputed claim is meritorious, but they do provide context that is missing when arbitration volume or total payments are discussed alone.
Eligibility objections are not eligibility determinations
The brief distinguishes between an insurer raising an eligibility objection and an IDR entity sustaining that objection. It cites federal sources placing adjudicated ineligibility findings generally in the 17% to 19% range, below figures sometimes used to describe payer objections.
That distinction does not make eligibility automatic. Venue, timing, batching, remittance information, plan type, and the underlying service can determine whether the federal process applies. Providers should evaluate those issues before committing resources to a filing.
Win rates do not eliminate process risk
Provider win rates are often used as shorthand for whether IDR is working. A claim-level analysis is more demanding. Final-offer selection, the support for each offer, the quality of the record, procedural defaults, and whether both parties complete required submissions can all influence the result.
A favorable trend cannot cure a missed deadline or an unsupported position. Providers still need a process that identifies viable claims, develops the record, and explains why the requested payment is supportable under the governing framework.
A determination is not always the end of recovery
RevGuard's brief also focuses on delayed or unpaid awards and the policy debate over enforcement. That issue is operationally important: obtaining a favorable determination and collecting the required payment are separate stages.
Providers should track payment deadlines, preserve the determination and related submissions, document follow-up, and evaluate available enforcement options when a payer does not comply. A recovery strategy that stops at the award may leave part of the value unrealized.
What providers should take from the data
- Screen eligibility before filing, including plan type, venue, service, and applicable law.
- Track open-negotiation and initiation deadlines at the claim level.
- Group claims only when the applicable batching rules support that treatment.
- Preserve remittance records, correspondence, clinical support, payment history, and prior submissions.
- Develop an offer position that fits the available evidence and dispute economics.
- Track payment after a determination and escalate noncompliance deliberately.
The broad lesson is disciplined selection. IDR can be an important recovery mechanism, but it works best when providers distinguish viable disputes from claims that belong in another forum or do not justify the cost of escalation.
Where legal review fits
Legal review connects the policy environment to the actual plan, claim record, deadlines, and remedy. Depending on those facts, the appropriate route may be open negotiation, federal IDR, a state process, contract escalation, ERISA litigation, or another recovery strategy.
No published statistic guarantees a result. Early review can, however, help preserve options, identify recurring payer behavior, and prevent viable claims from remaining indefinitely in an internal billing queue.